We are live on ! Find out more
TM

Taproot Management Portfolio holdings

AUM $530M
This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$530M
AUM Growth
-$87.6M
Cap. Flow
-$76.4M
Cap. Flow %
-14.42%
Top 10 Hldgs %
16.44%
Holding
243
New
96
Increased
35
Reduced
49
Closed
63

Top Buys

Rank Stock Value
1
AVB
AvalonBay Communities
AVB
+$8.86M
2
ABBV icon
AbbVie
ABBV
+$8M
3
ABT icon
Abbott
ABT
+$7.95M
4
KO icon
Coca-Cola
KO
+$7.75M
5
ELV icon
Elevance Health
ELV
+$7.47M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$11.3M
2
SNY icon
Sanofi
SNY
+$10.2M
3
MDT icon
Medtronic
MDT
+$10.2M
4
FDS icon
Factset
FDS
+$9.91M
5
GEV icon
GE Vernova
GEV
+$9.8M

Sector Composition

Rank Sector Weight
1 Healthcare 26.6%
2 Industrials 20.75%
3 Consumer Discretionary 16.07%
4 Consumer Staples 12.4%
5 Real Estate 11.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFGC icon
1
Performance Food Group
PFGC
$16.5B
$11M 2.07%
127,841
-10,474
-8% -$958K
WST icon
2
West Pharmaceutical
WST
$24.5B
$10.9M 2.07%
43,673
-1,085
-2% -$270K
ELV icon
3
Elevance Health
ELV
$86.5B
$9.4M 1.77%
32,111
+22,731
+242% +$7.47M
TMO icon
4
Thermo Fisher Scientific
TMO
$232B
$9.37M 1.77%
19,058
-640
-3% -$347K
AVB
5
DELISTED
AvalonBay Communities
AVB
$8.68M 1.64%
53,155
+50,699
+2,064% +$8.86M
ABBV icon
6
AbbVie
ABBV
$470B
$7.85M 1.48%
+36,080
New +$8M
KO icon
7
Coca-Cola
KO
$394B
$7.8M 1.47%
+102,508
New +$7.75M
FAST icon
8
Fastenal
FAST
$57.7B
$7.5M 1.42%
161,700
+125,404
+346% +$5.63M
RRX icon
9
Regal Rexnord
RRX
$10.8B
$7.37M 1.39%
+39,360
New +$7.32M
ABT icon
10
Abbott
ABT
$201B
$7.23M 1.37%
+70,425
New +$7.95M
ITT icon
11
ITT
ITT
$18.4B
$7.12M 1.34%
37,381
-33,934
-48% -$6.46M
AMH icon
12
American Homes 4 Rent
AMH
$12.4B
$6.79M 1.28%
243,202
+40,270
+20% +$1.22M
CVS icon
13
CVS Health
CVS
$119B
$6.68M 1.26%
93,028
-64,434
-41% -$4.96M
CUBE icon
14
CubeSmart
CUBE
$9.15B
$6.49M 1.23%
177,151
-47,420
-21% -$1.82M
CLX icon
15
Clorox
CLX
$12.7B
$6.22M 1.17%
+60,011
New +$6.8M
RPRX icon
16
Royalty Pharma
RPRX
$27.6B
$6.22M 1.17%
129,592
-155,095
-54% -$6.79M
OLLI icon
17
Ollie's Bargain Outlet
OLLI
$4.51B
$6.21M 1.17%
67,520
+50,224
+290% +$5.42M
FERG icon
18
Ferguson
FERG
$45B
$6.09M 1.15%
26,108
+14,706
+129% +$3.58M
CHD icon
19
Church & Dwight Co
CHD
$24.3B
$5.77M 1.09%
+61,791
New +$5.94M
EAT icon
20
Brinker International
EAT
$10.7B
$5.7M 1.08%
+39,934
New +$6.08M
MTD icon
21
Mettler-Toledo International
MTD
$28.1B
$5.66M 1.07%
4,485
-3,413
-43% -$4.6M
STZ icon
22
Constellation Brands
STZ
$23.1B
$5.63M 1.06%
37,544
-10,237
-21% -$1.58M
ASML icon
23
ASML
ASML
$670B
$5.44M 1.03%
4,117
+3,214
+356% +$4.4M
PFE icon
24
Pfizer
PFE
$163B
$5.42M 1.02%
+192,873
New +$5.13M
IEX icon
25
IDEX
IEX
$17B
$5.38M 1.02%
+28,398
New +$5.61M

Similar funds

Taproot Management's Q1 2026 Portfolio in Review

As of Q1 2026, Taproot Management held 243 positions worth $530M, down 14% from $617M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Taproot Management withdrew a net $76.4M in Q1 2026, closing 63 positions and reducing 49 holdings. Its most notable exit was Boston Scientific, an estimated $11.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 31% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Taproot Management opened a new position in AbbVie worth $7.85M.

  • Taproot Management's largest Q1 2026 buy was AbbVie: 36,080 shares worth $7.85M.
  • Taproot Management added most to AvalonBay Communities in Q1 2026, an estimated $8.86M increase.
  • Taproot Management's biggest Q1 2026 reduction was Jabil, cutting an estimated $9.26M.
  • Taproot Management fully exited Boston Scientific in Q1 2026, selling an estimated $11.3M.
  • Taproot Management's ten largest holdings make up 16% of its $530M portfolio in Q1 2026.
  • Taproot Management opened 96 new positions and closed 63 in Q1 2026.
  • Taproot Management's portfolio value fell 14% quarter-over-quarter to $530M.

Based on Taproot Management's 13F filing for Q1 2026, filed 13 May 2026.